Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

PT438 – Lynn Marie Morski, MD, JD – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy

PT438 – Lynn Marie Morski, MD, JD – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy

FromPsychedelics Today


PT438 – Lynn Marie Morski, MD, JD – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy

FromPsychedelics Today

ratings:
Length:
76 minutes
Released:
Sep 5, 2023
Format:
Podcast episode

Description

In this episode, David interviews the President of the Psychedelic Medicine Association, host of the Psychedelic Medicine Podcast, and Psychedelics Today advisory board member and Vital contributor: Lynn Marie Morski, MD, JD. She shares her journey with psychedelics and how they enabled her to leave a toxic job and pursue her passion for advocacy with vitality, and how important it is to focus your energy where it's best used. She talks about where we find ourselves in the psychedelic space based on Psychedelic Science 2023, as well as her recent TV appearances and the responsibility of preaching to the non-choir. And she discusses the idea of perfectionism in today's age; the need for psychedelic people to be involved in non-psychedelic conferences; the complications behind requiring physicians to experience psychedelics; the concept of it being malpractice for a physician to not mention psychedelic options; and the Psychedelic Medicine Association's upcoming virtual conference: Sana Symposium 2023, which happens October 26-27.  Morski talks a lot about the importance of educating healthcare professionals about psychedelics, debunking myths, and the need for standards in training therapists and primary care providers. She highlights how there is still no nationally-recognized certification for even ketamine providers, so how can people make informed decisions on who to trust? The Psychedelic Medicine Association is taking steps to improve this paradigm, offering a new course called "Managing Medical Risk in Patients Seeking Psilocybin Therapy," which will work to help clinicians make risk assessments for patients seeking psilocybin therapy – something that is not really being done today.  Click here to head to the show notes page.   
Released:
Sep 5, 2023
Format:
Podcast episode

Titles in the series (100)

A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.